Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia

Hai M. Nguyen, Eva M. Grössinger, Makoto Horiuchi, Kyle W. Davis, Lee-Way Jin, Izumi Maezawa, Heike Wulff

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Microglia are highly plastic cells that can assume different phenotypes in response to microenvironmental signals. Lipopolysaccharide (LPS) and interferon-γ (IFN-γ) promote differentiation into classically activated M1-like microglia, which produce high levels of pro-inflammatory cytokines and nitric oxide and are thought to contribute to neurological damage in ischemic stroke and Alzheimer's disease. IL-4 in contrast induces a phenotype associated with anti-inflammatory effects and tissue repair. We here investigated whether these microglia subsets vary in their K+ channel expression by differentiating neonatal mouse microglia into M(LPS) and M(IL-4) microglia and studying their K+ channel expression by whole-cell patch-clamp, quantitative PCR and immunohistochemistry. We identified three major types of K+ channels based on their biophysical and pharmacological fingerprints: a use-dependent, outwardly rectifying current sensitive to the KV1.3 blockers PAP-1 and ShK-186, an inwardly rectifying Ba2+-sensitive Kir2.1 current, and a Ca2+-activated, TRAM-34-sensitive KCa3.1 current. Both KV1.3 and KCa3.1 blockers inhibited pro-inflammatory cytokine production and iNOS and COX2 expression demonstrating that KV1.3 and KCa3.1 play important roles in microglia activation. Following differentiation with LPS or a combination of LPS and IFN-γ microglia exhibited high KV1.3 current densities (∼50 pA/pF at 40 mV) and virtually no KCa3.1 and Kir currents, while microglia differentiated with IL-4 exhibited large Kir2.1 currents (∼ 10 pA/pF at -120 mV). KCa3.1 currents were generally low but moderately increased following stimulation with IFN-γ or ATP (∼10 pS/pF). This differential K+ channel expression pattern suggests that KV1.3 and KCa3.1 inhibitors could be used to inhibit detrimental neuroinflammatory microglia functions.

Original languageEnglish (US)
JournalGLIA
DOIs
StateAccepted/In press - 2016

Fingerprint

Microglia
Lipopolysaccharides
Interleukin-4
Interferons
Cytokines
Phenotype
Dermatoglyphics
Plastics
Alzheimer Disease
Nitric Oxide
Anti-Inflammatory Agents
Adenosine Triphosphate
Immunohistochemistry
Stroke
Pharmacology
Polymerase Chain Reaction

Keywords

  • KCa3.1
  • Kir2.1
  • Kv1.3
  • Microglia
  • PAP-1
  • Potassium channel
  • TRAM-34

ASJC Scopus subject areas

  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia. / Nguyen, Hai M.; Grössinger, Eva M.; Horiuchi, Makoto; Davis, Kyle W.; Jin, Lee-Way; Maezawa, Izumi; Wulff, Heike.

In: GLIA, 2016.

Research output: Contribution to journalArticle

@article{63c2dcf3946c49e090b8a942db0d79a9,
title = "Differential Kv1.3, KCa3.1, and Kir2.1 expression in {"}classically{"} and {"}alternatively{"} activated microglia",
abstract = "Microglia are highly plastic cells that can assume different phenotypes in response to microenvironmental signals. Lipopolysaccharide (LPS) and interferon-γ (IFN-γ) promote differentiation into classically activated M1-like microglia, which produce high levels of pro-inflammatory cytokines and nitric oxide and are thought to contribute to neurological damage in ischemic stroke and Alzheimer's disease. IL-4 in contrast induces a phenotype associated with anti-inflammatory effects and tissue repair. We here investigated whether these microglia subsets vary in their K+ channel expression by differentiating neonatal mouse microglia into M(LPS) and M(IL-4) microglia and studying their K+ channel expression by whole-cell patch-clamp, quantitative PCR and immunohistochemistry. We identified three major types of K+ channels based on their biophysical and pharmacological fingerprints: a use-dependent, outwardly rectifying current sensitive to the KV1.3 blockers PAP-1 and ShK-186, an inwardly rectifying Ba2+-sensitive Kir2.1 current, and a Ca2+-activated, TRAM-34-sensitive KCa3.1 current. Both KV1.3 and KCa3.1 blockers inhibited pro-inflammatory cytokine production and iNOS and COX2 expression demonstrating that KV1.3 and KCa3.1 play important roles in microglia activation. Following differentiation with LPS or a combination of LPS and IFN-γ microglia exhibited high KV1.3 current densities (∼50 pA/pF at 40 mV) and virtually no KCa3.1 and Kir currents, while microglia differentiated with IL-4 exhibited large Kir2.1 currents (∼ 10 pA/pF at -120 mV). KCa3.1 currents were generally low but moderately increased following stimulation with IFN-γ or ATP (∼10 pS/pF). This differential K+ channel expression pattern suggests that KV1.3 and KCa3.1 inhibitors could be used to inhibit detrimental neuroinflammatory microglia functions.",
keywords = "KCa3.1, Kir2.1, Kv1.3, Microglia, PAP-1, Potassium channel, TRAM-34",
author = "Nguyen, {Hai M.} and Gr{\"o}ssinger, {Eva M.} and Makoto Horiuchi and Davis, {Kyle W.} and Lee-Way Jin and Izumi Maezawa and Heike Wulff",
year = "2016",
doi = "10.1002/glia.23078",
language = "English (US)",
journal = "GLIA",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia

AU - Nguyen, Hai M.

AU - Grössinger, Eva M.

AU - Horiuchi, Makoto

AU - Davis, Kyle W.

AU - Jin, Lee-Way

AU - Maezawa, Izumi

AU - Wulff, Heike

PY - 2016

Y1 - 2016

N2 - Microglia are highly plastic cells that can assume different phenotypes in response to microenvironmental signals. Lipopolysaccharide (LPS) and interferon-γ (IFN-γ) promote differentiation into classically activated M1-like microglia, which produce high levels of pro-inflammatory cytokines and nitric oxide and are thought to contribute to neurological damage in ischemic stroke and Alzheimer's disease. IL-4 in contrast induces a phenotype associated with anti-inflammatory effects and tissue repair. We here investigated whether these microglia subsets vary in their K+ channel expression by differentiating neonatal mouse microglia into M(LPS) and M(IL-4) microglia and studying their K+ channel expression by whole-cell patch-clamp, quantitative PCR and immunohistochemistry. We identified three major types of K+ channels based on their biophysical and pharmacological fingerprints: a use-dependent, outwardly rectifying current sensitive to the KV1.3 blockers PAP-1 and ShK-186, an inwardly rectifying Ba2+-sensitive Kir2.1 current, and a Ca2+-activated, TRAM-34-sensitive KCa3.1 current. Both KV1.3 and KCa3.1 blockers inhibited pro-inflammatory cytokine production and iNOS and COX2 expression demonstrating that KV1.3 and KCa3.1 play important roles in microglia activation. Following differentiation with LPS or a combination of LPS and IFN-γ microglia exhibited high KV1.3 current densities (∼50 pA/pF at 40 mV) and virtually no KCa3.1 and Kir currents, while microglia differentiated with IL-4 exhibited large Kir2.1 currents (∼ 10 pA/pF at -120 mV). KCa3.1 currents were generally low but moderately increased following stimulation with IFN-γ or ATP (∼10 pS/pF). This differential K+ channel expression pattern suggests that KV1.3 and KCa3.1 inhibitors could be used to inhibit detrimental neuroinflammatory microglia functions.

AB - Microglia are highly plastic cells that can assume different phenotypes in response to microenvironmental signals. Lipopolysaccharide (LPS) and interferon-γ (IFN-γ) promote differentiation into classically activated M1-like microglia, which produce high levels of pro-inflammatory cytokines and nitric oxide and are thought to contribute to neurological damage in ischemic stroke and Alzheimer's disease. IL-4 in contrast induces a phenotype associated with anti-inflammatory effects and tissue repair. We here investigated whether these microglia subsets vary in their K+ channel expression by differentiating neonatal mouse microglia into M(LPS) and M(IL-4) microglia and studying their K+ channel expression by whole-cell patch-clamp, quantitative PCR and immunohistochemistry. We identified three major types of K+ channels based on their biophysical and pharmacological fingerprints: a use-dependent, outwardly rectifying current sensitive to the KV1.3 blockers PAP-1 and ShK-186, an inwardly rectifying Ba2+-sensitive Kir2.1 current, and a Ca2+-activated, TRAM-34-sensitive KCa3.1 current. Both KV1.3 and KCa3.1 blockers inhibited pro-inflammatory cytokine production and iNOS and COX2 expression demonstrating that KV1.3 and KCa3.1 play important roles in microglia activation. Following differentiation with LPS or a combination of LPS and IFN-γ microglia exhibited high KV1.3 current densities (∼50 pA/pF at 40 mV) and virtually no KCa3.1 and Kir currents, while microglia differentiated with IL-4 exhibited large Kir2.1 currents (∼ 10 pA/pF at -120 mV). KCa3.1 currents were generally low but moderately increased following stimulation with IFN-γ or ATP (∼10 pS/pF). This differential K+ channel expression pattern suggests that KV1.3 and KCa3.1 inhibitors could be used to inhibit detrimental neuroinflammatory microglia functions.

KW - KCa3.1

KW - Kir2.1

KW - Kv1.3

KW - Microglia

KW - PAP-1

KW - Potassium channel

KW - TRAM-34

UR - http://www.scopus.com/inward/record.url?scp=84990215091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990215091&partnerID=8YFLogxK

U2 - 10.1002/glia.23078

DO - 10.1002/glia.23078

M3 - Article

JO - GLIA

JF - GLIA

SN - 0894-1491

ER -